$ICL

ICL Group Ltd.

No enriched coverage for $ICL in the last 7 days.

No SEC Form 4 filings for $ICL in the last 30 days.

Low

ICL Financials: Revenue Breakdown, Margins & Competitor Comparison

The article analyzes ICL Group Ltd.'s financial performance, focusing on its revenue breakdown, profitability margins, and competitor comparison within the Agricultural Chemicals industry. It highlights that Phosphate Solutions is ICL's largest revenue contributor, and the company maintains a gross margin of 27.51% despite negative operating and net margins. ICL's financial metrics are benchmarked against industry peers like MOS and SMG to provide context for its market valuation.

ICL Group Ltd. $ICL is Y.D. More Investments Ltd's 5th Largest Position

Y.D. More Investments Ltd increased its stake in ICL Group Ltd. (ICL) by 5.5% in Q4, making it their 5th largest holding, valued at $107.5 million. ICL reported Q4 EPS in line with estimates at $0.09 but missed revenue forecasts at $1.70 billion, while analysts maintain a "Hold" rating with an average price target of $6.10. The company currently trades near $5.24, has a market cap of $6.76 billion, and offers an annualized dividend of $0.19, yielding approximately 3.6%.

ICL Group (NYSE: ICL) EVP discloses large stock option grants

ICL Group Ltd.'s EVP, Uri Perelman, has filed an initial ownership report detailing his existing stock option holdings, which include options for 1,139,990 ordinary shares at a $6.03 exercise price expiring in 2029 and 739,400 ordinary shares at a $6.93 exercise price expiring in 2030. These options are held by a trustee and vest over several years. The filing is an initial disclosure and does not indicate any new purchases or sales of shares.